News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
665,380 Results
Type
Article (54800)
Company Profile (700)
Press Release (609880)
Section
Business (186035)
Career Advice (2564)
Deals (33828)
Drug Delivery (93)
Drug Development (75358)
Employer Resources (129)
FDA (15648)
Job Trends (15606)
News (319194)
Policy (31026)
Tag
Academia (2779)
Alliances (45670)
Alzheimer's disease (1287)
Approvals (15619)
Artificial intelligence (145)
Bankruptcy (287)
Best Places to Work (12264)
Biotechnology (486)
Breast cancer (191)
Cancer (1398)
Cardiovascular disease (110)
Career advice (2117)
Cell therapy (298)
Clinical research (60081)
Collaboration (503)
Compensation (275)
COVID-19 (2369)
C-suite (116)
Data (1422)
Diabetes (167)
Diagnostics (6477)
Earnings (71369)
Employer resources (113)
Events (109311)
Executive appointments (424)
FDA (16374)
Funding (456)
Gene therapy (197)
GLP-1 (602)
Government (4183)
Healthcare (20183)
Infectious disease (2457)
Inflammatory bowel disease (119)
Interviews (435)
IPO (16652)
Job creations (3836)
Job search strategy (1848)
Layoffs (396)
Legal (6923)
Lung cancer (197)
Manufacturing (215)
Medical device (13955)
Medtech (13959)
Mergers & acquisitions (17438)
Metabolic disorders (438)
Neuroscience (1616)
NextGen Class of 2024 (7321)
Non-profit (4936)
Northern California (1754)
Obesity (237)
Opinion (223)
Patents (116)
People (54703)
Pharmaceutical (137)
Phase I (18641)
Phase II (26140)
Phase III (20217)
Pipeline (500)
Postmarket research (2496)
Preclinical (8121)
Radiopharmaceuticals (256)
Rare diseases (264)
Real estate (6362)
Regulatory (21409)
Research institute (2515)
Resumes & cover letters (415)
Southern California (1510)
Startups (3494)
United States (16230)
Vaccines (508)
Weight loss (168)
Date
Last 7 days (184)
Last 30 days (1670)
Last 365 days (35947)
2025 (102)
2024 (36723)
2023 (41492)
2022 (50827)
2021 (56005)
2020 (55951)
2019 (49849)
2018 (37247)
2017 (31950)
2016 (30653)
2015 (36100)
2014 (29034)
2013 (28566)
2012 (25148)
2011 (25410)
2010 (23888)
Location
Africa (838)
Arizona (141)
Asia (39008)
Australia (7000)
California (4018)
Canada (1466)
China (327)
Colorado (178)
Connecticut (204)
Europe (89673)
Florida (560)
Georgia (144)
Illinois (416)
Indiana (242)
Maryland (686)
Massachusetts (3223)
Michigan (190)
Minnesota (321)
New Jersey (1171)
New York (1136)
North Carolina (879)
Northern California (1754)
Ohio (156)
Pennsylvania (964)
South America (1163)
Southern California (1510)
Texas (599)
Utah (112)
Washington State (443)
665,380 Results for "new england peptide llc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Gilead Announces New England Journal of Medicine Publication of PURPOSE 2 Results
November 27, 2024
·
5 min read
Biotech Beach
Favorable Oncocyte VitaGraft Kidney Study Results Published in the New England Journal of Medicine
Oncocyte Corporation, a precision diagnostics company, announced that favorable data regarding its lead product VitaGraft™ Kidney was published in the New England Journal of Medicine.
May 30, 2024
·
8 min read
Business
New England Biolabs® and Inorevia to partner on novel solutions for the preparation of challenging samples for next generation sequencing
New England Biolabs (NEB ®) and Inorevia announce a collaboration to develop automated workflows to maximize data quality by preparation of sequence-ready libraries from challenging samples using NEBNext® library preparation reagents on Inorevia’s Magelia® automation platform.
June 18, 2024
·
4 min read
Drug Development
Investigational targeted oral peptide JNJ-2113 demonstrated positive results in moderate-to-severe plaque psoriasis in Phase 2b study published in New England Journal of Medicine
Johnson & Johnson today announced publication in the New England Journal of Medicine (NEJM) of the Phase 2b FRONTIER 1 trial results for JNJ-2113.
February 7, 2024
·
16 min read
Drug Development
New England Journal of Medicine Publishes Efficacy and Safety Data of Targeted Oral Peptide JNJ-2113 in a Phase 2b Moderate-To-Severe Plaque Psoriasis Study
Protagonist Therapeutics, Inc. (NASDAQ:PTGX) (“Protagonist” or the “Company”) today announced publication in the New England Journal of Medicine (NEJM) of the Phase 2b FRONTIER 1 trial evaluating JNJ-2113 in adults living with moderate-to-severe plaque psoriasis (PsO).
February 7, 2024
·
9 min read
Drug Development
Dupixent® (dupilumab) Positive Phase 3 Data in Children 1 to 11 Years of Age with Eosinophilic Esophagitis Published in the New England Journal of Medicine
Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) and Sanofi today announced the New England Journal of Medicine(NEJM) has published results from a positive Phase 3 trial for Dupixent® (dupilumab) in children aged 1 to 11 years with eosinophilic esophagitis (EoE).
June 26, 2024
·
22 min read
Business
New England Journal of Medicine Publishes Positive Results of Cefepime-Taniborbactam from Phase 3 CERTAIN-1 Study of Patients with Complicated Urinary Tract Infection
Venatorx Pharmaceuticals, Melinta Therapeutics LLC (“Melinta”), and Menarini Group today announced that The New England Journal of Medicine (NEJM) published the results of the CERTAIN-1 Phase 3 clinical study of the investigational agent cefepime-taniborbactam for the treatment of adult patients with complicated urinary tract infections (cUTI) and acute pyelonephritis (AP), including those with bacteremia.
February 20, 2024
·
9 min read
BioMidwest
Stacey Lasser of Mednet to Present at the 2nd Annual Clinical Outsourcing Group New England Conference in Boston
Mednet, a healthcare technology company, today announced Senior Project Manager Stacey Lasser will present at the 2nd Annual Clinical Outsourcing Group (COG) New England conference in Boston, Massachusetts from April 23 – 24, 2024.
April 19, 2024
·
2 min read
Drug Development
Neurocrine Biosciences Announces Publication of Primary CAHtalyst™ Pediatric Phase 3 Study Results of Crinecerfont for the Treatment of CAH in The New England Journal of Medicine
Neurocrine Biosciences, Inc. (Nasdaq: NBIX) today announced that the primary study results from its CAHtalyst™ Pediatric Phase 3 study investigating crinecerfont for the treatment of congenital adrenal hyperplasia (CAH) due to 21-hydroxylase deficiency have been published in The New England Journal of Medicine online edition and will appear in a future print issue of the journal.
June 3, 2024
·
11 min read
Press Releases
BridgeBio Pharma Announces Publication in the New England Journal of Medicine of Phase 2 PROPEL 2 Study of Infigratinib for Children Living with Achondroplasia
November 18, 2024
·
8 min read
1 of 66,538
Next